Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques LeLorier

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
The Canadian Journal of Cardiology|August 18, 2006
Treatment of dyslipidemia: we don't know all we think we knowJacques LeLorier
The Canadian Journal of Cardiology|February 2, 2006
The value of lowering blood pressureJacques LeLorier,
Pharmacoepidemiology and Drug Safety|January 11, 2019
Pharmacologically pertinent period of effect (PPPE)Melanie Suissa, Jacques LeLorier
JAMA|April 26, 2007
Clopidogrel and long-term outcomes after drug-eluting stent implantationAlexis Matteau, Jacques LeLorier
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|January 11, 2008
Impact of the socioeconomic status on the probability of receiving formulary restricted thiazolidine (TZDs)Marc Dorais, Jacques LeLorier
Annals of Internal Medicine|February 14, 2022
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous ThromboembolismPhilippe Brouillard, Jacques LeLorier
The New England Journal of Medicine|August 17, 2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromesJean-Michel Paradis, Jacques LeLorier
The New England Journal of Medicine|February 3, 2007
Effect of ramipril on the incidence of diabetesBrian J Potter, Jacques LeLorier
Pharmacoeconomics|December 13, 2005
A willingness-to-pay assessment of parents' preference for shorter duration treatment of acute otitis media in childrenDelphine Gueylard Chenevier, Jacques LeLorier
Stroke|July 10, 2002
TimelessLise M Bjerre, Jacques LeLorier
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
The Canadian Journal of Cardiology|August 18, 2006
Treatment of dyslipidemia: we don't know all we think we knowJacques LeLorier
The Canadian Journal of Cardiology|February 2, 2006
The value of lowering blood pressureJacques LeLorier,
Pharmacoepidemiology and Drug Safety|January 11, 2019
Pharmacologically pertinent period of effect (PPPE)Melanie Suissa, Jacques LeLorier
JAMA|April 26, 2007
Clopidogrel and long-term outcomes after drug-eluting stent implantationAlexis Matteau, Jacques LeLorier
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|January 11, 2008
Impact of the socioeconomic status on the probability of receiving formulary restricted thiazolidine (TZDs)Marc Dorais, Jacques LeLorier
Annals of Internal Medicine|February 14, 2022
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous ThromboembolismPhilippe Brouillard, Jacques LeLorier
The New England Journal of Medicine|August 17, 2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromesJean-Michel Paradis, Jacques LeLorier
The New England Journal of Medicine|February 3, 2007
Effect of ramipril on the incidence of diabetesBrian J Potter, Jacques LeLorier
Pharmacoeconomics|December 13, 2005
A willingness-to-pay assessment of parents' preference for shorter duration treatment of acute otitis media in childrenDelphine Gueylard Chenevier, Jacques LeLorier
Stroke|July 10, 2002
TimelessLise M Bjerre, Jacques LeLorier
Pageof 10